Concord Biotech

Concord Biotech Ltd Quarterly Results

NSEBSE

₹1,650.7

(0.13%)

Apr 24, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Dec-2024	Sept-2024	Jun-2024	Mar-2024	Dec-2023
Gross Sales	244.22	310.18	215.8	318.97	240.8
Excise Duty	0	0	0	0	0
Net Sales	244.22	310.18	215.8	318.97	240.8
Other Operating Income	0	0	0	0	0
Other Income	16.56	10.03	11.66	10.81	11.21
Total Income	260.78	320.21	227.46	329.78	252
Total Expenditure	146.27	176.46	134.52	186.88	134.87
PBIDT	114.51	143.75	92.94	142.9	117.14
Interest	0.1	0.1	0.24	0.46	0.5
PBDT	114.42	143.65	92.7	142.44	116.64
Depreciation	13.26	13.31	13.18	13.72	13.54
Minority Interest Before NP	0	0	0	0	0
Tax	23.69	34.06	19.39	29.98	25.8
Deferred Tax	1.54	0.53	0.53	3.73	-0.27
Reported Profit After Tax	75.92	95.74	59.59	95.02	77.57
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	75.92	95.74	59.59	95.02	77.57
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	75.92	95.74	59.59	95.02	77.57
EPS (Unit Curr.)	7.26	9.15	5.7	9.08	7.41
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	10.46	10.46	10.46	10.46	10.46
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	46.88	46.34	43.06	44.8	48.64
PBDTM(%)	46.85	46.31	42.95	44.65	48.43
PATM(%)	31.08	30.86	27.61	29.78	32.21